a public good project by the
Synthesis
Company
of California

© 2026

Brian D. Guth | doi.page

0 works0 citations0 h-index

Brian D. Guth

Boehringer Ingelheim (Germany)(DE)

Publications by Year

Research Areas

Cardiac electrophysiology and arrhythmias, Cardiac Imaging and Diagnostics, Heart Rate Variability and Autonomic Control, Cardiovascular Function and Risk Factors, Ion channel regulation and function

Most-Cited Works

→ Measurement of regional myocardial blood flow with multiple colored microspheres.(1991)379 cited
→ 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes(2007)282 cited
→ Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation.(1992)252 cited
→ Ischemia of the dog heart induces the appearance of a cardiac mRNA coding for a protein with migration characteristics similar to heat-shock/stress protein 71.(1986)152 cited
→ Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise.(1988)132 cited
→ Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs.(1987)128 cited

→ Mechanisms of augmented segment shortening in nonischemic areas during acute ischemia of the canine left ventricle.(1985)123 cited

→ Effects of isoflurane, ketamine-xylazine and a combination of medetomidine, midazolam and fentanyl on physiological variables continuously measured by telemetry in Wistar rats(2014)118 cited

→ Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis.(1987)111 cited

→ Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society(2011)103 cited